These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 23968890)
21. Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development. Sharma A; Knollmann-Ritschel B Viruses; 2019 Feb; 11(2):. PubMed ID: 30781656 [TBL] [Abstract][Full Text] [Related]
22. Emergence of a new epidemic/epizootic Venezuelan equine encephalitis virus in South America. Rico-Hesse R; Weaver SC; de Siger J; Medina G; Salas RA Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5278-81. PubMed ID: 7777497 [TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus. Phillpotts RJ; Jones LD; Howard SC Vaccine; 2002 Feb; 20(11-12):1497-504. PubMed ID: 11858855 [TBL] [Abstract][Full Text] [Related]
24. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus. Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698 [TBL] [Abstract][Full Text] [Related]
25. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus. Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884 [TBL] [Abstract][Full Text] [Related]
27. Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5' noncoding region and glycoproteins. Spotts DR; Reich RM; Kalkhan MA; Kinney RM; Roehrig JT J Virol; 1998 Dec; 72(12):10286-91. PubMed ID: 9811777 [TBL] [Abstract][Full Text] [Related]
28. Neutralising antibodies for Mayaro virus in Pantanal, Brazil. Pauvolid-Corrêa A; Juliano RS; Campos Z; Velez J; Nogueira RM; Komar N Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):125-33. PubMed ID: 25742272 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses. Barber TL; Walton TE; Lewis KJ Am J Vet Res; 1978 Apr; 39(4):621-5. PubMed ID: 646197 [TBL] [Abstract][Full Text] [Related]
36. A Quantitative Real-Time RT-PCR Assay for the Detection of Vina-Rodriguez A; Eiden M; Keller M; Hinrichs W; Groschup MH Biomed Res Int; 2016; 2016():8543204. PubMed ID: 28042576 [No Abstract] [Full Text] [Related]
37. [The vaccines based on the replicon of the venezuelan equine encephalomyelitis virus against viral hemorrhagic fevers]. Petrov AA; Plekhanova TM; Sidorova ON; Borisevich SV; Makhlay AA Vopr Virusol; 2015; 60(3):14-8. PubMed ID: 26281301 [TBL] [Abstract][Full Text] [Related]
38. TC-83 vaccine protects against airborne or subcutaneous challenge with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus. Phillpotts RJ; Wright AJ Vaccine; 1999 Feb; 17(7-8):982-8. PubMed ID: 10067707 [TBL] [Abstract][Full Text] [Related]
39. Epidemic Venezuelan equine encephalitis in North America in 1971: vertebrate field studies. Sudia WD; McLean RG; Newhouse VF; Johnston JG; Miller DL; Trevino H; Bowen GS; Sather G Am J Epidemiol; 1975 Jan; 101(1):36-50. PubMed ID: 1119481 [TBL] [Abstract][Full Text] [Related]
40. Association of Venezuelan equine encephalitis virus subtype IE with two equine epizootics in Mexico. Oberste MS; Fraire M; Navarro R; Zepeda C; Zarate ML; Ludwig GV; Kondig JF; Weaver SC; Smith JF; Rico-Hesse R Am J Trop Med Hyg; 1998 Jul; 59(1):100-7. PubMed ID: 9684636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]